Wednesday, 31 July 2013

Devices used to inspect the internal lining of the gastrointestinal tract are termed as gastrointestinal endoscopic devices. Gastrointestinal (GI) tract includes small intestine, large intestine, duodenum, colon, stomach, cecum and rectum. Any infection or abnormalities in function of this GI tract is detected for using gastrointestinal endoscopic devices. These devices are helpful in detecting the cause of abdominal bleeding, vomiting, persistent pain, inflammation and tumor affecting the esophagus, duodenum and stomach. In addition they also help in treating these GI diseases. Various GI diseases include ulcer, gastroesophageal reflux disease, hemorrhoids, colon cancer, diverticulitis, bowel syndrome and Crohn’s disease.

Gastrointestinal endoscopic devices include thin flexible tube, light attached to thin flexible tube and a visualizer. Other components of this device are viewing sheath, power source, rheostat, lasers, insufflators, battery box, bulbs, fiberoptic lighting, hand instruments, electrosurgical and radiofrequency instruments. The process of detecting GI tract abnormalities through GI endoscopic devices is termed as gastrointestinal endoscopy. This process starts with anesthetizing the patient and then putting thin wire in the GI tract through mouth. The internal structure image is displayed on the visualizer. This image helps the physician to detect and treat the GI infections.

Changing lifestyle has changed the diet pattern. The new diet has reduced the intake of various healthy foods which increases the incidence of digestive tract problems. In addition, increase in GI diseases has also triggered the growth of this market. Recently in year 2011, 1 million of the total worldwide population has been detected with colon and rectum cancer. Weight management treatment has also contributed in its growth since this therapy includes gastric banding and bypass surgery. Global increase in disposable income has also boosted the growth of this market. Despite all the advantages, the growth of this market would be hampered due to lack of sufficient reimbursement policies and reduced government funding in various nations such as Europe and U.S. respectively. In addition, high costs and delayed approval process would also hinder the growth of this market.

Some of the major market players in this industry are Covidien Ltd., Boston Scientific Corporation, Conmed Corporation, Johnson & Johnson Ltd., Fujinon Ltd., Stryker Corporation and other significant players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America

Asia Pacific

Europe

Rest of the World

This report provides comprehensive analysis of

Market growth drivers

Factors limiting market growth

Current market trends

Market structure

Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Market Research Reports : Transparency
Market Research published new market report "RFID Blood Monitoring
Systems (Blood Refrigerators and Freezers) Market - Global Industry Analysis,
Size, Share, Growth, Trends and Forecast, 2013-2019" the global RFID blood refrigerators and
freezers market was valued at USD 40.9 million in 2012 and is expected to grow
at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 174.2
million in 2019.

The global RFID
blood refrigerators and freezers market is expected to undergo rapid growth of
22.8% from 2013 to 2019. This growth is majorly attributed to the rapid
adoption of RFID technology in the healthcare industry and growing need for
efficient management of blood and blood products to minimize transfusion
errors. Growing trend of consolidation of healthcare facilities has resulted in
growth of their size. This is followed by the increase in the volume of
inventory of blood and blood products. Consistency in the occurrence of
transfusion and storage errors despite the use of bar-coding and note-taking
systems also influence the demand for RFID blood tracking solutions in blood
banks and hospitals.

The major concern
for hospitals and blood centers is patient safety, minimal wastage of blood
products and minimization of blood transfusion errors. Consistent prevalence of
blood transfusion errors and to minimize the time consuming paperwork for
inventory management, hospitals and blood banks throughout the world have begun
to explore RFID tracking system for its potential in efficient inventory and
supply management. Furthermore, privatization of healthcare infrastructure has
led to a growth in the number of large sized blood banks and hospitals in many
developing countries which require efficient catering to the transfusion needs
of patients. This phenomenon serves as a potential opportunity for the RFID
blood refrigerators and freezers manufacturers to introduce their products in
these regions.

North America was
the dominant geographical market for RFID blood refrigerators and freezers in
2012. RFID systems for Real Time Location Systems, asset tracking and inventory
management are mature technologies in this region and many healthcare
institutions have already adopted RFID to reduce errors and increase
productivity. The US has the highest adoption rate of RFID in its healthcare
system. The advanced healthcare system of this country and existence of large
sized blood banks have been responsible for the high level of RFID tracking
technology utilized in its healthcare infrastructure. Currently, North America
encompasses more than 50% of the global RFID blood refrigerators and freezers
market.

Moreover, the
adoption of RFID blood refrigerators is high in blood banks than in hospital
blood centers. This is due to the existence of more number of blood banks
across all regions and the volume stored and supplied to and from blood banks
is larger than that in hospital blood centers.

At present, the
global market for RFID blood refrigerators and freezers has few players.
Companies such as Biolog ID, Terso Solutions and Magellan technologies are the
dominant players in this market. Recent FDA approval to the first RFID-enabled
Blood tracking system will encourage more companies to enter this market thereby
increasing the competition.

The global RFID
blood refrigerators and freezers market is segmented as follows:

Transparency
Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers.

We
are privileged with highly experienced team of Analysts, Researchers and
Consultants, who use proprietary data sources and various tools and techniques
to gather, and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to sustain a
competitive edge.

Tuesday, 30 July 2013

In vitro diagnostic test are the kind of medical tests which are performed to detect diseases, infections and pathological conditions. These tests are performed in test tubes or in controlled environment outside the patient’s body. In vitro diagnostic tests are executed with the help of reagents, reagent products, control materials and apparatus such as laser and cell, to examine specimens like blood and tissue.

To detect wide array of diseases, a variety of in vitro diagnostic tests are performed such as immunoassay, molecular diagnostics, hematology, flow cytometry, coagulation and clinical chemistry. Immunoassay is a biochemical test, used to detect the presence of analyte in the specimen with the use of immunoglobulin or antibody. They are used to detect pregnancy, heart diseases, prostate cancer and others. Molecular diagnostic test detects specific sequences in DNA or RNA including single nucleotide polymorphism (SNP), deletion, insertion and rearrangement which may or may not be associated with the diseases. They are helpful in detecting infectious and genetic diseases, pharmacogenomic and cancer.

Hematology diagnostic tests use blood as the sample to diagnose illness or disorders. They are helpful in detection of cancer, blood diseases and blood protein. Flow cytometry diagnostic tests are performed to count and sort cell, detect biomarker and protein in the sample which is passed through an electronic detection apparatus. They are majorly used to detect blood cancer. Coagulation diagnostic tests are involved in diagnosis of hemostasis system through coagulometer. Clinical chemistry tests are performed to detect the significant amount of substances in urine, blood, body fluid and tissues.

In vitro diagnostic test provides better and accurate detection of different diseases and hence helps in providing specific treatment for the same. Rise in incidence of chronic and infectious diseases amongst aging population coupled with increasing awareness in developed nations such as U.S. and Europe have augmented the growth of this market. Lack of awareness and disposable income in developing nations has negatively impacted the growth of this market.

Some of the market players in this industry segment are Roche Diagnostics, Abbott Laboratories, Siemens Medical, Beckman Coulter Inc. and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Monday, 29 July 2013

Market Research Reports : Transparency
Market Research published new market report "Blood Banking Market-
Global Industry Analysis,Size, Share, Growth, Trends
and Forecast, 2013-2019," the global
blood processing devices and consumables market was valued at USD 27.27 billion
in 2012 and is estimated to reach a market worth USD 49.16 billion in 2019 at a
CAGR of 8.9% from 2013 to 2019.

The growth of the blood processing devices
and consumables market is driven by factors such as increase in aging
population, increasing cancer therapies, emergence of infectious diseases (HIV
and Hepatitis) and significant rise in surgical procedures. In addition, strict
government regulations across the world are also positively impacting market growth.
Moreover, manufacturers are developing improved and automated products for
collection, processing and storage of blood and blood components. According to
WHO, it is estimated that global population over age 60 years would double from
11% (2000) to 22% (2050). People aged 60 and above are more prone to cancer
risk and other surgical procedures. Hence, graying population and increasing
demand of cell therapy will act as driving factors for the growth of this
market.

Blood processing devices and consumables
market is a rapidly developing field, and have been witnessing numerous
technological advancements Growth of the market is influenced under the rising
demand for pathogen-free blood. Blood being a vital component of the body, is
routinely used in wide range of hospital procedures for transplantations,
cancer therapies and other forms of surgeries. Therefore, safe blood supply is
integral in surgical and other blood transfusion procedures. Manufacturers are
developing automated products to reduce blood associated risks. Automaton of
devices reduces human intervention, requires less number of professionals and
also reduces the risk of pathogen development.

Therefore, automated devices and
consumables have been gaining lot of popularity in recent times. Automated cell
processors and automated blood collection devices have become one of the
standard procedures for blood procurement, thereby further giving a boost to
this market. Other major technological advancements include blood bags with
in-built filters, blood collection monitors, and tube sealers which are further
supplementing the market growth.

Blood bags used in each step of blood
collection, processing, storage and delivery account for the largest share in
blood processing consumables segment. Coagulation reagents, which are used for
detecting bleeding disorders and coagulation rate is the fastest growing
segment of blood processing consumables market and is poised to grow at a CAGR
of 13.3%.

North America accounts for the largest
share of the blood processing devices and consumables market owing to the
developed economies in this region. In North America, more than 27 million
units of blood and blood components are transfused each year.

Therefore, to
meet this huge blood requirement, the market is characterized by government
support, increased public awareness and presence of technologically advanced
equipments. Despite the developed countries holding a major share, Asia-Pacific
region is poised to show a significant growth in the coming years. Expanding
population bases in countries such as India and China, coupled with increasing
epidemic of diseases such as dengue and chikunguniya will boost the market
demand and successive growth. Additionally, the government in these nations is
focused towards improving healthcare infrastructure, thus, in turn, further
propelling the growth of this market.

Blood processing devices and consumable
market is witnessing intense competition among the players which are willing to
offer complete reliable and cost-effective products. Some of the significant
key players in this market include Terumo BCT, Fresenius Kabi, Haemonetics
Corporation, Immucor, Inc., Abbott Diagnostics and others. Manufacturers are
entering into strategic alliances with other players for the development and
commercialization of new and innovative products, for maintaining the
competitive edge.

The global blood processing devices and
consumables market is segmented into the following categories:

Monday, 22 July 2013

Minimally invasive surgery (MIS) is known for its efficiency and its low risk procedures. These procedures are safe, patient friendly, very precise in nature, and have improved surgical outcomes. MIS ensures the patient’s quick recovery and also shortens the hospital stay. These factors have led to an increase in the demand for MIS across the globe. The prime advantages of MIS are reduction in post-operative difficulties, better cosmetic result, quick recovery, and the relative cost effectiveness.

With the increase in pressure to pull down healthcare costs and simultaneously improve the surgical outcome, MIS has been successful in replacing conventional invasive surgical methods. With MIS, the pressure of high investment in treatments has been considerably reduced. Favorable reimbursement system and provisions have further induced the demand for MIS. On the other hand, the high investment cost for such devices is one of the concerns for the adoption of this method on a large scale.

The market of MIS can be classified on the basis of product types, technology, and applications. The major product types used in MIS are endoscopic devices, monitoring and visualization systems, electrosurgical devices, imaging systems, and some others. The technology segment comprises of medical robots and capsule endoscopes. The applications segment is further divided into cosmetic surgery, gastrointestinal surgery, orthopedic surgery, cryosurgery, and laparoscopic surgery. The emerging economies of Asia-Pacific will also undergo impressive growth in the given period of forecast. Some of the major players of this market are Stryker Corporation, Conmed Corp., Fujifilm Holdings Inc., Ethicon Endo Surgery Inc., Accellent Inc., and Covidien PLC.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Market Research Reports : Transparency
Market Research published new market report “Cardiovascular Monitoring &
Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast,2011 - 2016”global
cardiovascular monitoring & diagnostic devices market is estimated to be
USD 797million in 2011 and expected to reach USD 1.3 billion in 2016 at a CAGR
of 8.8% over the period 2010 to 2016. The ECG Monitoring Equipments segment is
the leading market contributor with a share of around 51% in 2010.

Cardiovascular Diseases (CVDs) are the largest
cause of deaths globally, around 17.3 million people died from cardiovascular
diseases in 2008. This amounts to 30% of all deaths. Of these deaths, an
estimated 7.3 million were due to coronary heart disease and 6.2 million were
due to stroke. Low- and middle-income countries are the largest affectedwith
CVDs. An estimated 80% of CVD deaths take place in low- and middle-income
countries. By 2030, almost 23.6 million people will die from CVDs, mainly from
heart disease and stroke and are projected to be the single leading causes of
death.

With the number of people suffering from cardiovascular diseases and the
condition upswingsglobally, the demand for cardiovascular devices is
growing.Around 30 million people are severely affected by cardiovascular diseases
every year. A considerable market growth is provided in the stress testing
systems and diagnostics all over the world by the emerging markets.The overall
sales in 2009 was USD 34.9 billion as compared to the projected sale for 2010,
estimated to be USD 36.2 billion at a compound annual growth rate of 3.6% in
the global market for cardiovascular devices. There are two sub-segments
accounting for the high demand—cardiac rhythm management and cardiovascular
monitoring and diagnostic devices.

In 2009, the sales in diagnostic cardiovascular devices amounted to USD 11.1
billion, and in 2015, is estimated to reach USD 15.5 billion with a CAGR of
5.7% The U.S. represents the largest market in the worldwide cardiovascular
disease market and Europe represents the second largest market, followed by
Japan.The global Cardiovascular Monitoring and Diagnostic (CMD) devices
marketis estimated to reach USD 1.3 billion in 2016, growing at a CAGR of 8.8%
during 2010 – 2016.This market comprises of Electrocardiograph (ECG) monitoring
equipment, ECG stress testing systems, Holter monitoring systems, ECG data
monitoring systems, event monitoring systems, cardiovascular monitoring and
diagnostic devices and cardiopulmonary stress testing systems. The largest
segment growing at 10.7% over the period 2010 – 2016 and valued at USD 410.5
million in 2010 was the ECG monitoring equipment.

GE Healthcare, Philips Healthcare, Nihon Kohden, Cardiac Science Corp (now
OptoCircuits) and Schiller AG are the leading companies in the global
Cardiovascular Monitoring and Diagnostic devices market, with a combined share
of more than 60%.

·Scope and Overview

The objective of
the study on “Global Cardiovascular Monitoring & Diagnostic Devices Market”
is to gain detailed market insights for cardiovascular monitoring &
diagnostic devicesused to treat CVDs in developing economies where the reported
CVD incidence is very high and also in developed economies where advanced
technologies are being rapidly implemented. The market is analyzed on the basis
of growth trends, ongoing developments, market penetration and revenue
share.The report also covers the strategies followed by “Global
Cardiovascular Monitoring & Diagnostic Devices Market” players.

·Segmentation &
Analysis

The report
segments and analyzes the “Global Cardiovascular Monitoring & DiagnosticDevices
Market” on the basis of following sub-categories:

·Major Geographic Markets

U.S.

U.K.

Germany

France

Italy

Spain

Japan

China

India

Australia

Brazil

Canada

This section
provides in-depth analysis of “Global Cardiovascular Monitoring &
Diagnostic Devices Market” that includes market size and growth forecast for
each geography and opportunities prevailing in the particular geography.

This section
provides in-depth analysis of cardiovascular devices market size and growth
forecast for each sub segment, driving factors and challenges prevailing in the
overall and at the micro market levels, and opportunities and future outlook
for all the levels.

·

Cardiovascular Monitoring
& Diagnostic Devices Market

ECG Monitoring
Equipment

Holter Monitor

Stress Testing

Cardiac Monitor

This section
provides in-depth analysis of cardiovascular monitoring & diagnostic
devices marketsize and growth forecast for each sub segment and opportunities
and future outlook for all the levels.

·

Product Pipeline Analysis

This section
analyses the new product developments and impact on the market.

·

Company Profiles of Top
Players

This section
provides brief overview of top market players in the “Global
Cardiovascular Monitoring & Diagnostic Devices Market”. The
profile of each company includes brief overview, key financials, product &
services, recent developments and key strategies adopted by the player.

Transparency
Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insight for thousands
of decision makers.

We
are privileged with highly experienced team of Analysts, Researchers and
Consultants, who use proprietary data sources and various tools and techniques
to gather, and analyze information. Our business offerings represent the latest
and the most reliable information indispensable for businesses to sustain a
competitive edge.

Thursday, 18 July 2013

Market Research Reports : Transparency
Market Research published new market report "X-Ray Market: Global Market Analysis, Size and Forecast (2011 -
2017)", Global X-Ray market was worth USD 7.3 billion in 2011 and is
expected to reach USD 9.1 billion in 2017, growing at a CAGR of 3.6% from 2011
to 2017. In the overall global market, American region is expected to maintain
its lead position in terms of revenue till 2017.

X-ray is one of
the diagnostic imaging techniques through which images of the internal
structures of a human body, especially bones are obtained, which facilitates
early diagnosis of diseases. X-ray has the largest market share among the key
equipment of diagnostic imaging market, which includes CT, MRI, Ultrasound and Nuclear
Imaging. The increase in aging population and rise in patients with chronic
diseases are driving the X-ray market growth.

The X-ray market
is segmented into General X-ray and Cardiovascular X-ray. The General X ray
market was about 2.6 times the Cardiovascular X-ray market in 2011. The General
X-ray market will grow at a CAGR of 3.5% from 2012 to 2017, whereas
Cardiovascular X-ray market is estimated to grow at a CAGR of 3.7% during the
same period. General X-ray enjoys some of the advantages over Cardiovascular
X-ray including low cost, efficient and easy to operate, which supports the
healthy growth of general X-ray market.

The American
region is expected to account for the largest share of global X-ray market
revenue at USD 3.0 billion in 2012. The region is expected to reach USD 3.4
billion in 2017 at a CAGR of 2.9% from 2012 to 2017. The ROW region (including
theMiddle East and Africa) is expected to have the highest growth rate of 8.7%
during the same period.

Transparency Market Research is a global market
intelligence company, providing global business information reports and
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and techniques
to gather, and analyze information.

Our data
repository is continuously updated and revised by a team of research experts,
so that it always reflects the latest trends and information. With a broad
research and analysis capability, Transparency Market Research employs rigorous
primary and secondary research techniques in developing distinctive data sets
and research material for business reports.

Tuesday, 16 July 2013

Market Research Reports : Transparency Market Research published new market report "RFID Enabled Smart Cabinets Market for Expensive Hospitals Supplies
- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 -
2018," the global market for RFID enabled smart cabinets was valued at USD
286.7 million in 2011 and it is expected to reach an estimated value of USD
609.8 million in 2018, growing at a CAGR of 11.3% from 2012 to 2018.

RFID Smart
Cabinet technology has been instrumental in reducing manual efforts in
maintaining, tracking and managing inventory in hospitals and promises to
reduce losses and misplacement of supplies. These cabinets are responsible for
the tracking of expensive drugs and devices as well as maintaining viability of
drugs by alerting the medical team in case a drug has expired. RFID is in use
in the healthcare sector for the last two decades and promises significant
savings to hospitals in terms of losses due to human errors in hospital
inventory mismanagement, loss due to theft and incorrect prescriptions for
medications.

RFID cabinets in
hospitals are common in North America particularly in the United States, where
there are few governmental restrictions on the usage of radiofrequencies. The
adoption in United States is expected to further increase as awareness among
the medical community increases. Along with this, it is expected that in coming
years, competitive pricing will help stimulate the growth of these cabinets in
hospitals and other healthcare facilities.

Exhaustive data
was collected on hospital specialties which deal with expensive materials such
as radiology and oncology, orthopedic surgery, cardiovascular surgery, cath
labs, and ophthalmology among other departments. The current trend of
installing cabinets was then collected from hospitals and manufacturing
companies through personal interviews with industry experts and hospital
procurement departments with several participants spread across the countries
under focus.

The major drivers
for the growth of the RFID smart cabinets market is the urgent need for
inventory control in hospitals to reduce loss, awareness of RFID technology and
its applications, governmental regulations for inventory management, low cost
of supporting network equipment (WiFi, ZigBee, Ultrasound) and increasing
hospital funding for infrastructure in emerging economies of Latin America such
as Brazil and Argentina.

Strong factors
restricting the growth include initial costs of installing devices and
subsequent maintenance which are quite high. Many hospitals consider it as an
unnecessary luxury as they give priority to expanding beds in the hospitals. In
Europe, a large number of hospitals have been shutting down and reducing the
customer base. Shrinking customer base will pose serious challenges to the
growth of the market. Besides these, several countries have not opened
radiofrequency bandwidths for healthcare and public use. Moreover, established
bar-coding techniques are deeply rooted in the healthcare systems of today.
There is a reluctance to shift to modern technologies s these simple manual
techniques are currently sufficient.

The key
competitors in this segment are WaveMark, Terso Solutions, Solstice Medical,
Tagsys, Mobile Aspects and LogiTag. There are numerous other local and regional
players across the world such as BayNexus, ARC Technologies.

The global RFID
enabled smart cabinets market is categorized into the following segments:

TransparencyMarket Research is a global market
intelligence company, providing global business information reports and
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers. We are
privileged with highly experienced team of Analysts, Researchers, and
Consultants, who use proprietary data sources and various tools and techniques
to gather, and analyze information.

Our data repository is continuously updated and revised
by a team of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.

The
surgical equipment market is driven by strong economic growth in Japan, Europe and
in emerging economies such as India and China. Increased
healthcare expenditure, improving standards of living and longer life
expectancies are the major factors driving the growth of the surgical equipment
market. Moreover, growing demand of outpatient surgeries, increase in the
number of healthcare centers, the rise in the surgical procedures performed
globally; technological innovations and growing preference for minimally
invasive surgeries are also driving the growth of the surgical equipment
market.

Our
research indicates faster growth in number of surgical performed in emerging
economies in comparison with developed economies. This is primarily due to the
higher economic growth and fast improving healthcare facilities in these
economies, and declining repayment levels in the U.S.

High
competition in the global surgical equipment market is observed with local and
international players capturing respective slice of the surgical pie. The
faster addition of operating facilities compounded with growing number of
hospitals in emerging economies provides healthy growth opportunities for
established as well as new players .The top four players in the global surgical
equipment market accounted for about 64% market share in 2011. Ethicon was the
clear leader in the global surgical equipment market accounting for 34.4%
market share in 2011.

This
report is an effort to identify driving forces behind the global and regional
surgical equipment market over the next six years. The report provides
extensive analysis of the surgical equipment market and current market trends
and presents a comprehensive assessment on the basis of:

Transparency Market Research (TMR) is a market intelligence
company providing global business research reports and consulting services.TMR
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and
consultants use proprietary data sources along with various tools and
techniques to gather and analyze information.TMR business offerings represent
the latest and the most reliable information which is indispensable for
businesses to sustain their competitive edge.